Sopeña B, Limeres J, García-Caballero L, Diniz-Freitas M, Seoane J, Diz P
Department of Internal Medicine, Complexo Hospitalario Universitario, University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Medical-Surgical Dentistry Research Group (OMEQUI), Health Research Institute of Santiago de Compostela (IDIS), University of Santiago de Compostela (USC), Santiago de Compostela, Spain.
Dysphagia. 2018 Feb;33(1):133-135. doi: 10.1007/s00455-017-9861-8. Epub 2017 Nov 11.
We report the case of a 77-year-old male with a history of aortic stenosis and interstitial lung disease, who debuted 3 years ago with an outbreak of necrotic and very painful canker sores. The severity of the lesions and their refractory response to treatment led to several hospital admissions and multiple consultations to different specialists (ENT, rheumatology, dermatology, ophthalmology, cardiology, and internal medicine). During this time, the patient received central parenteral nutrition with an episode of catheter-related septicemia, and he came to require psychiatric assistance for autolytic ideation. Numerous diagnostic tests were performed with inconclusive results, including biopsy of the lesion (histological study, immunohistochemistry for CD68 + , CD4 + , CD8 + , CD20 + , MCT +, and cytomegalovirus, PAS, Grocott-Gomori and Zielh-Neelsen staining, and in situ hybridization for Epstein Barr virus). Numerous treatments were unsuccessfully tested until thalidomide was administered, thus completely remitting lesions but leaving retractable scarring sequelae. Since then, the patient has had two recurrences, coinciding with the reduction of thalidomide dosages, which were controlled by increasing the dose of the immunomodulator. Recurrent necrotizing major aphthous stomatitis (Sutton's disease) is a clinical variant of recurrent aphthous stomatitis that may have a dramatic course. Unfortunately, the lack of etiopathogenetic uniformity precludes any specific treatment. In severe cases, immunomodulators, including thalidomide, may represent a valid therapeutic option.
我们报告了一例77岁男性患者,有主动脉瓣狭窄和间质性肺疾病病史,3年前首次出现坏死性且非常疼痛的口腔溃疡。病变的严重程度及其对治疗的难治性反应导致多次住院,并向不同专科医生(耳鼻喉科、风湿病科、皮肤科、眼科、心脏病科和内科)进行了多次咨询。在此期间,患者接受了中心肠外营养,出现了一次与导管相关的败血症,并且因有自我溶解的想法而需要精神科帮助。进行了许多诊断测试,但结果均不明确,包括病变活检(组织学研究、CD68 +、CD4 +、CD8 +、CD20 +、MCT +和巨细胞病毒的免疫组织化学、PAS、Grocott-Gomori和Ziehl-Neelsen染色以及爱泼斯坦-巴尔病毒原位杂交)。在使用沙利度胺之前,许多治疗方法都未成功,使用沙利度胺后病变完全缓解,但留下了可退缩的瘢痕后遗症。从那时起,患者复发了两次,均与沙利度胺剂量减少同时发生,通过增加免疫调节剂剂量得以控制。复发性坏死性重型阿弗他口炎(萨顿病)是复发性阿弗他口炎的一种临床变体,其病程可能很严重。不幸的是,由于缺乏病因发病机制的一致性,无法进行任何特异性治疗。在严重病例中,包括沙利度胺在内的免疫调节剂可能是一种有效的治疗选择。